Macitentan Phase 1 study
Phase 1
- Conditions
- Japanese healthy male subjects
- Registration Number
- JPRN-jRCT2080222838
- Lead Sponsor
- Actelion Pharmaceuticals Japan Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 16
Inclusion Criteria
Signed and dated written informed consent prior to enrollment in the study
Healthy Japanese adult males
Body mass index (BMI) ≥ 18 and ≤ 28 kg/m2 at screening. BMI = weight (kg) / [height (m)]2
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method